BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05216432-completion@plaintrial.com
DTSTAMP:20261027T203430Z
DTSTART;VALUE=DATE:20270430
SUMMARY:First-in-Human Study of Mutant-selective PI3Kα Inhibitor\, RLY-260
 8\, as a Single Agent in Patients With Advanced Solid Tumors and in Combin
 ation With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients Wi
 th Advanced Solid Tumors or Advanced Breast Cancer — estimated completio
 n date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05216432
URL:https://plaintrial.com/trial/NCT05216432
END:VEVENT
END:VCALENDAR